Cardiovascular diseases research

We are advancing research into new therapies for personalized medicine for patients with cardiovascular disease.

Cardiovascular disease is the leading cause of death and hospitalization in western countries and, in particular, in Spain. Their incidence increases progressively with aging and with the presence of highly prevalent risk factors in society such as hypertension, chronic kidney disease and metabolic disorders such as obesity and diabetes.

Cardiovascular diseases encompass pathologies affecting the heart and blood vessels.

At the Cima University of Navarra, we conduct research to investigate the origin, causes and evolution of the most prevalent cardiovascular pathologies with the greatest prevalence and social impact. Specifically, we focus on the study of heart failure and atherosclerotic lesions in the vasculature, as well as their associated complications. 

We research in close collaboration with physicians from the Clínica Universidad de Navarra with the aim of responding to the existing medical need to establish more effective individualized treatments to improve the prognosis of patients with cardiovascular disease.

Need more information?

If you are interested in learning more about our research, please contact us.

Cardiovascular diseases we investigate


Icono blanco microscopio
The patient, at the center of our research

 

To understand the mechanisms that cause damage to the endocardium, myocardium and arterial wall in processes involving heart failure, atrial fibrillation or stroke.


ldentify new therapeutic targets related to the mechanisms involved in these prevalent cardiovascular diseases.
 


To establish biomarkers for early detection of these pathologies with diagnostic and preventive utility.
 


To design new drugs for more effective personalized treatment of heart failure and cardiac and cerebral ischemic events.
 

Our research programs and platforms

Cima's research is multidisciplinary, carried out by teams of professionals from various fields who collaborate with clinicians from the Clínica Universidad de Navarra.